Generic Vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed With Alopecia Areata: Evidence from TARGET-DERM AA. J of Skin 2024, 8 (6), s471. https://doi.org/10.25251/skin.8.supp.471.